Allergan Announces Settlement Of Patent Litigation On DELZICOL

(RTTNews) - Allergan Inc. (AGN) announced the company, along with Qualicaps, have reached a settlement regarding their litigation with Zydus Pharma and Cadila Healthcare on a patent in connection with Allergan's DELZICOL. The '180 patent related to DELZICOL will expire on April 13, 2020. The company has not disclosed additional details regarding the settlement.

As a result of the settlement, and if approved by FDA, Zydus and Cadila may be able to market their generic version of DELZICOL in the U.S. beginning on March 1, 2020, or earlier under certain circumstances.